These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


266 related items for PubMed ID: 15318303

  • 1. Chemical and biological evaluation of technetium (I) tricarbonyl complexes with EHIDA and DPD. 99m (I) complexes of EHIDA and DPD.
    Djokić DDj, Janković DLj, Stamenković LLj, Pirmettis I.
    Nucl Med Rev Cent East Eur; 2004; 7(1):1-5. PubMed ID: 15318303
    [Abstract] [Full Text] [Related]

  • 2. Labeling, characterization, and in vivo localization of a new 90Y-based phosphonate chelate 2,3-dicarboxypropane-1,1-diphosphonic acid for the treatment of bone metastases: Comparison with 99mTc-DPD complex.
    Djokić DDj, Janković DLj, Nikolić NS.
    Bioorg Med Chem; 2008 Apr 15; 16(8):4457-65. PubMed ID: 18331797
    [Abstract] [Full Text] [Related]

  • 3. 99mTc-labelled compounds prepared with sodium dithionite as reducing agent.
    Vilcek S, Kalincák M, Machán V.
    Nuklearmedizin; 1981 Dec 15; 20(6):283-9. PubMed ID: 6460222
    [Abstract] [Full Text] [Related]

  • 4. Comparison of chromatographic methods for quality control of DMSA complexes with 99mTc and 188Re at (III) and (V) oxidation states.
    Garnuszek P, Pawlak D, Maurin M, Jankovic D, Karczmarczyk U, Mikołajczak R.
    Nucl Med Rev Cent East Eur; 2012 Aug 30; 15(2):95-100. PubMed ID: 22936501
    [Abstract] [Full Text] [Related]

  • 5. Preparation and biological evaluation of cyclopentadienyl-based 99mTc-complexes [(Cp-R)99mTc(CO)3] mimicking benzamides for malignant melanoma targeting.
    N'Dongo HW, Raposinho PD, Fernandes C, Santos I, Can D, Schmutz P, Spingler B, Alberto R.
    Nucl Med Biol; 2010 Apr 30; 37(3):255-64. PubMed ID: 20346865
    [Abstract] [Full Text] [Related]

  • 6. Synthesis, characterization, and biological evaluation of neutral nitrido technetium(V) mixed ligand complexes containing dithiolates and aminodiphosphines. A novel system for linking technetium to biomolecules.
    Bolzati C, Benini E, Cazzola E, Jung C, Tisato F, Refosco F, Pietzsch HJ, Spies H, Uccelli L, Duatti A.
    Bioconjug Chem; 2004 Apr 30; 15(3):628-37. PubMed ID: 15149191
    [Abstract] [Full Text] [Related]

  • 7. Preparation, 99mTc-labeling and biodistribution studies of a PNA oligomer containing a new ligand derivative of 2,2'-dipicolylamine.
    Gasser G, Jäger K, Zenker M, Bergmann R, Steinbach J, Stephan H, Metzler-Nolte N.
    J Inorg Biochem; 2010 Nov 30; 104(11):1133-40. PubMed ID: 20674031
    [Abstract] [Full Text] [Related]

  • 8. Asymmetrical nitrido tc-99m heterocomplexes as potential imaging agents for benzodiazepine receptors.
    Boschi A, Uccelli L, Duatti A, Bolzati C, Refosco F, Tisato F, Romagnoli R, Baraldi PG, Varani K, Borea PA.
    Bioconjug Chem; 2003 Nov 30; 14(6):1279-88. PubMed ID: 14624645
    [Abstract] [Full Text] [Related]

  • 9. Is (99m)Tc-labelled pamidronate a better agent than (99m)Tc-medronate for bone imaging?
    Kumar V, Kumar D, Howman-Giles RB, Little DG.
    Nucl Med Commun; 2007 Feb 30; 28(2):101-7. PubMed ID: 17198350
    [Abstract] [Full Text] [Related]

  • 10. Novel polar single amino acid chelates for technetium-99m tricarbonyl-based radiopharmaceuticals with enhanced renal clearance: application to octreotide.
    Maresca KP, Marquis JC, Hillier SM, Lu G, Femia FJ, Zimmerman CN, Eckelman WC, Joyal JL, Babich JW.
    Bioconjug Chem; 2010 Jun 16; 21(6):1032-42. PubMed ID: 20402463
    [Abstract] [Full Text] [Related]

  • 11. Development of a novel 99mTc-chelate-conjugated bisphosphonate with high affinity for bone as a bone scintigraphic agent.
    Ogawa K, Mukai T, Inoue Y, Ono M, Saji H.
    J Nucl Med; 2006 Dec 16; 47(12):2042-7. PubMed ID: 17138748
    [Abstract] [Full Text] [Related]

  • 12. Characterisation and biodistribution of two neutral 99mTc(CO)3 complexes with a tridentate ligand.
    Rattat D, Cleynhens B, Bormans G, Terwinghe C, Verbruggen A.
    Bioorg Med Chem Lett; 2005 Oct 01; 15(19):4192-5. PubMed ID: 16084082
    [Abstract] [Full Text] [Related]

  • 13. [Use of redox polymers for insulin labeling with technetium (99mTc)].
    Komárek P, Kleisner I, Konopková M, Komárková I.
    Ceska Slov Farm; 1999 Sep 01; 48(5):218-20. PubMed ID: 10566241
    [Abstract] [Full Text] [Related]

  • 14. Influence of the denticity of ligand systems on the in vitro and in vivo behavior of (99m)Tc(I)-tricarbonyl complexes: a hint for the future functionalization of biomolecules.
    Schibli R, La Bella R, Alberto R, Garcia-Garayoa E, Ortner K, Abram U, Schubiger PA.
    Bioconjug Chem; 2000 Sep 01; 11(3):345-51. PubMed ID: 10821650
    [Abstract] [Full Text] [Related]

  • 15. Synthesis, characterization and biological evaluation of novel neutral fac-M(CO)3(SNO) complexes (M=Re, 99mTc) bearing the o-methoxyphenylpiperazine moiety.
    Chiotellis A, Tsoukalas C, Pelecanou M, Pirmettis I, Papadopoulos M.
    Appl Radiat Isot; 2012 Jun 01; 70(6):957-64. PubMed ID: 22464790
    [Abstract] [Full Text] [Related]

  • 16. Biological evaluation of glucose and deoxyglucose derivatives radiolabeled with [99mTc(CO)3(H2O)3]+ core as potential melanoma imaging agents.
    Dapueto R, Castelli R, Fernández M, Chabalgoity JA, Moreno M, Gambini JP, Cabral P, Porcal W.
    Bioorg Med Chem Lett; 2011 Dec 01; 21(23):7102-6. PubMed ID: 22014828
    [Abstract] [Full Text] [Related]

  • 17. First evaluation of a 99mTc-tricarbonyl complex, 99mTc(CO)3(LAN), as a new renal radiopharmaceutical in humans.
    Lipowska M, He H, Malveaux E, Xu X, Marzilli LG, Taylor A.
    J Nucl Med; 2006 Jun 01; 47(6):1032-40. PubMed ID: 16741314
    [Abstract] [Full Text] [Related]

  • 18. Synthesis, characterization and pre-clinical evaluation of (99m) Tc-tricarbonyl complexes as potential myocardial perfusion imaging agents.
    Ellis BL, Gorshkov NI, Lumpov AA, Miroslavov AE, Yalfimov AN, Gurzhiy VV, Suglobov DN, Braddock R, Adams JC, Smith AM, Prescott MC, Sharma HL.
    J Labelled Comp Radiopharm; 2013 Dec 01; 56(14):700-7. PubMed ID: 24339008
    [Abstract] [Full Text] [Related]

  • 19. A study on nitroimidazole-99mTc(CO)3 complexes as hypoxia marker: some observations towards possible improvement in in vivo efficacy.
    Mallia MB, Subramanian S, Mathur A, Sarma HD, Banerjee S.
    Nucl Med Biol; 2014 Aug 01; 41(7):600-10. PubMed ID: 24856280
    [Abstract] [Full Text] [Related]

  • 20. Synthesis and evaluation of a new 99mTc(I)-tricarbonyl complex bearing the 5-nitroimidazol-1-yl moiety as potential hypoxia imaging agent.
    Giglio J, Dematteis S, Fernández S, Cerecetto H, Rey A.
    J Labelled Comp Radiopharm; 2014 May 30; 57(6):403-9. PubMed ID: 24692093
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.